ASC
Showing 1 - 25 of 559
Diabetic Foot Ulcer Trial in Bucheon, Seoul (ALLO-ASC-DFU, Vehicle sheet)
Recruiting
- Diabetic Foot Ulcer
- ALLO-ASC-DFU
- Vehicle sheet
-
Bucheon, Gyeonggi-do, Korea, Republic of
- +3 more
Nov 15, 2023
Advanced Solid Tumors Trial (ASC61 200 mg 1, ASC61 200 mg 2, ASC61 300 mg)
Recruiting
- Advanced Solid Tumors
- ASC61 200 mg 1
- +4 more
-
Omaha, NebraskaNebraska Cancer Specialists
Oct 27, 2022
Hemophilia A Trial in Little Rock (ASC618)
Recruiting
- Hemophilia A
- ASC618
-
Little Rock, ArkansasArkansas Children's Hospital
Jan 30, 2023
Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)
Not yet recruiting
- Nonalcoholic Steatohepatitis (NASH)
- ASC41 2 mg
- +2 more
- (no location specified)
Jan 30, 2023
Acne Vulgaris Trial in Shanghai (ASC40 25mg, ASC40 50mg, ASC40 75mg)
Active, not recruiting
- Acne Vulgaris
- ASC40 25mg
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Dec 1, 2022
Healthy, COVID-19 Trial in Hangzhou (ASC11 tablets, Placebo, RTV tablets)
Recruiting
- Healthy
- COVID-19
- ASC11 tablets
- +2 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University School of M
Feb 9, 2023
Breast Hypoplasia and Facial Ageing Trial in Copenhagen (ASC enriched lipofilling, Standard Lipofilling)
Completed
- Breast Hypoplasia and Facial Ageing
- ASC enriched lipofilling
- Standard Lipofilling
-
Copenhagen, Søborg, DenmarkStemform
Nov 24, 2022
Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis Trial in Hangzhou (2mg of ASC41, 4mg of ASC41 (2 tablets of 2
Not yet recruiting
- Non-alcoholic Fatty Liver Disease
- Non-alcoholic Steatohepatitis
- 2mg of ASC41
- +2 more
-
Hangzhou, Zhejiang, ChinaThe affiliated Hospital of Hangzhou Normal University
Jul 13, 2022
Dystrophic Epidermolysis Bullosa Trial (ALLO-ASC-SHEET, Vehicle Control)
Not yet recruiting
- Dystrophic Epidermolysis Bullosa
- ALLO-ASC-SHEET
- Vehicle Control
- (no location specified)
Feb 15, 2022
Healthy Trial in Changsha (ASC42, Placebo)
Completed
- Healthy
- ASC42
- Placebo
-
Changsha, Hunan, ChinaXiangya Boai Rehabilitation Hospital
Jun 28, 2022
HIV-1-infection, HIV, PD-L1 Gene Mutation Trial in Beijing (ASC22 1mg/kg, ASC22 2.5mg/kg, Antiretroviral Therapy)
Recruiting
- HIV-1-infection
- +2 more
- ASC22 1mg/kg
- +3 more
-
Beijing, Beijing, ChinaThe FifthMedical Center of the General Hospital of thePeoples Li
Jun 28, 2022
Primary Biliary Cholangitis Trial (ASC42 5 mg, ASC42 10 mg, ASC42 15 mg)
Not yet recruiting
- Primary Biliary Cholangitis
- ASC42 5 mg
- +3 more
- (no location specified)
Mar 9, 2022
Recurrent Glioblastoma Trial in Beijing (ASC40 tablets, Placebo tablets, Bevacizumab)
Recruiting
- Recurrent Glioblastoma
- ASC40 tablets
- +2 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital,Capital Medical University
Jun 28, 2022
HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)
Not yet recruiting
- HPV Infection
- HPV-Related Cervical Carcinoma
- FluBHPVE6E7
- Placebo
- (no location specified)
Apr 24, 2023
Chronic Hepatitis b Trial in Beijing (ASC22, sodium chloride)
Active, not recruiting
- Chronic Hepatitis b
- ASC22
- sodium chloride
-
Beijing, ChinaPeking University First Hospital
Jul 18, 2022
HIV Trial (ASC22 group)
Not yet recruiting
- HIV Infections
- ASC22 group
- (no location specified)
Mar 4, 2022
Lateral Epicondylitis Trial in Seoul (ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection)
Completed
- Lateral Epicondylitis
- ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection
-
Seoul, Korea, Republic ofSeoul National University College of Medicine
Feb 21, 2022
Effects of ASC Secretome on Human Osteochondral Explants
Recruiting
- Osteoarthritis
- ASC secretome
-
Milano, MI, ItalyIRCCS Istituto Ortopedico Galeazzi
Dec 2, 2021
Vaginal Flora Imbalance, ASC-US, LSIL Trial in Roma (Lactobacillus Crispatus M247)
Recruiting
- Vaginal Flora Imbalance
- +3 more
- Lactobacillus Crispatus M247
-
Roma, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 29, 2023
Autism Spectrum Disorder, Gastrointestinal Dysfunction, Leaky Gut Syndrome Trial (Adipose tissue derived mesenchymal
Not yet recruiting
- Autism Spectrum Disorder
- +4 more
- Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
- (no location specified)
Nov 1, 2022
1L-PEG-Asc Solution for Bowel Preparation in"Open Access"
Completed
- Bowel Preparation
- use of a very low-volume 1L-PEG plus ascorbate (plenvu) or low-volume 2L-PEG plus ascorbate (moviprep) for bowel preparation in open access colonoscopy
-
Carpi, Modena, ItalyAzienda USL Modena
Feb 15, 2022
Evaluate Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical
Active, not recruiting
- Burn
- ALLO-ASC-DFU
-
Seoul, Korea, Republic ofHallym university Medical Center
Jul 19, 2021